Zurich Insurance has formally filed with EU regulators for approval of its £8.1 billion acquisition of Lloyd's specialist insurer Beazley, a significant procedural step in what would be one of the largest specialty insurance deals in recent memory. The filing signals Zurich's confidence in regulatory clearance and brings the transaction closer to completion, though EU merger control timelines typically span 25 working days for Phase I, with potential Phase II risk if competition concerns arise.

Beazley shares are now squarely in deal-spread territory, meaning price action will be driven by the market's evolving read on regulatory approval probability and deal timing rather than operating fundamentals. Key things to watch: whether the EU opens a Phase II investigation (materially lengthening the timeline), any competing bids, and whether UK FCA or PRA approvals run in parallel without complication. Zurich's own stock may face modest pressure given the premium implied by the deal size.